These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 10598340

  • 1. [Cognition and driving in schizophrenic patients under treatment with risperidone vs. haloperidol].
    Dittert S, Soyka M, Winter C, Möller HJ.
    Fortschr Neurol Psychiatr; 1999 Nov; Suppl 2():S70-3. PubMed ID: 10598340
    [No Abstract] [Full Text] [Related]

  • 2. Effects of haloperidol and risperidone on psychomotor performance relevant to driving ability in schizophrenic patients compared to healthy controls.
    Soyka M, Winter C, Kagerer S, Brunnauer M, Laux G, Möller HJ.
    J Psychiatr Res; 2005 Jan; 39(1):101-8. PubMed ID: 15504428
    [Abstract] [Full Text] [Related]

  • 3. Effects of antipsychotics on cognitive performance in drug-naive schizophrenic patients.
    Lee SM, Chou YH, Li MH, Wan FJ, Yen MH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun 30; 31(5):1101-7. PubMed ID: 17475386
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, randomized study comparing the efficacy and safety of sertindole and risperidone in patients with treatment-resistant schizophrenia.
    Kane JM, Potkin SG, Daniel DG, Buckley PF.
    J Clin Psychiatry; 2011 Feb 30; 72(2):194-204. PubMed ID: 20673553
    [Abstract] [Full Text] [Related]

  • 5. Course of recovery of cognitive impairment in patients with schizophrenia: a randomised double-blind study comparing sertindole and haloperidol.
    Gallhofer B, Jaanson P, Mittoux A, Tanghøj P, Lis S, Krieger S.
    Pharmacopsychiatry; 2007 Nov 30; 40(6):275-86. PubMed ID: 18030652
    [Abstract] [Full Text] [Related]

  • 6. Marked improvement of tardive dystonia after replacing haloperidol with risperidone in a schizophrenic patient.
    Yoshida K, Higuchi H, Hishikawa Y.
    Clin Neuropharmacol; 1998 Nov 30; 21(1):68-9. PubMed ID: 9579290
    [Abstract] [Full Text] [Related]

  • 7. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J.
    Clin Ther; 2008 Dec 30; 30(12):2378-86. PubMed ID: 19167596
    [Abstract] [Full Text] [Related]

  • 8. The relationship of Akathisia with treatment emergent suicidality among patients with first-episode schizophrenia treated with haloperidol or risperidone.
    Seemüller F, Lewitzka U, Bauer M, Meyer S, Musil R, Schennach R, Riedel M, Doucette S, Möller HJ.
    Pharmacopsychiatry; 2012 Nov 30; 45(7):292-6. PubMed ID: 22614116
    [Abstract] [Full Text] [Related]

  • 9. Symptoms in neuroleptic-naive, first-episode schizophrenia: response to risperidone.
    Kopala LC, Fredrikson D, Good KP, Honer WG.
    Biol Psychiatry; 1996 Feb 15; 39(4):296-8. PubMed ID: 8645777
    [No Abstract] [Full Text] [Related]

  • 10. [Risperidone in the treatment of chronic schizophrenia: multicenter study comparative to haloperidol].
    López Ibor JJ, Ayuso JL, Gutiérrez M, Guimon J, Herraiz ML, Chinchilla A, Ayuso JL, González Pinto A, Eguiluz I, Fernández A.
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1996 Feb 15; 24(4):165-72. PubMed ID: 8984849
    [Abstract] [Full Text] [Related]

  • 11. Double-blind comparison of risperidone and haloperidol in schizophrenic and schizoaffective psychoses.
    Cesková E, Svestka J.
    Pharmacopsychiatry; 1993 Jul 15; 26(4):121-4. PubMed ID: 7694306
    [Abstract] [Full Text] [Related]

  • 12. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia.
    Reilly JL, Harris MS, Keshavan MS, Sweeney JA.
    Arch Gen Psychiatry; 2006 Nov 15; 63(11):1189-97. PubMed ID: 17088499
    [Abstract] [Full Text] [Related]

  • 13. Long-term effects of risperidone versus haloperidol on verbal memory, attention, and symptomatology in schizophrenia.
    Rémillard S, Pourcher E, Cohen H.
    J Int Neuropsychol Soc; 2008 Jan 15; 14(1):110-8. PubMed ID: 18078537
    [Abstract] [Full Text] [Related]

  • 14. Negative correlation between alpha-1-acid-glycoprotein plasma level and response to haloperidol in the acute treatment of schizophrenia.
    Levinson I, Levine S.
    Biol Psychiatry; 1995 Aug 01; 38(3):198-200. PubMed ID: 7578667
    [No Abstract] [Full Text] [Related]

  • 15. Schizophrenia and severe tardive dyskinesia responsive to risperidone.
    Kopala LC, Honer WG.
    J Clin Psychopharmacol; 1994 Dec 01; 14(6):430-1. PubMed ID: 7533794
    [No Abstract] [Full Text] [Related]

  • 16. [Zotepine: treatment of schizophrenic patients with predominantly negative symptoms. A double-blind study vs. haloperidol].
    Barnas C, Stuppäck CH, Miller C, Haring C, Sperner-Unterweger B, Fleischhacker WW.
    Fortschr Neurol Psychiatr; 1991 Sep 01; 59 Suppl 1():36-40. PubMed ID: 1683338
    [Abstract] [Full Text] [Related]

  • 17. Assessing a drug's cost-benefits.
    Raleigh F.
    Psychiatr Serv; 1996 Aug 01; 47(8):877-8. PubMed ID: 8837167
    [No Abstract] [Full Text] [Related]

  • 18. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec 01; (31):21-30. PubMed ID: 8968652
    [No Abstract] [Full Text] [Related]

  • 19. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP, Eerdekens E, Berry SA, Eerdekens M.
    J Clin Psychiatry; 2004 Aug 01; 65(8):1084-9. PubMed ID: 15323593
    [Abstract] [Full Text] [Related]

  • 20. [Initial use of risperidone in the treatment of acutely exacerbated schizophrenic patients--an interim analysis].
    Pajonk FG, Schreiner A, Peters S, Rettig K, Degner D, Rüther E.
    Fortschr Neurol Psychiatr; 2003 May 01; 71(5):249-54. PubMed ID: 12740756
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.